TITLE

CLINIC ROUNDUP

PUB. DATE
May 2010
SOURCE
BioWorld Today;5/25/2010, Vol. 21 Issue 100, p7
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
This section offers news briefs on clinical trials in the biopharmaceutical industry as of May 25, 2010. The Israeli Ministry of Health has given its approval for the Phase II trial of orally administered CF101 in glaucoma by Can-Fite BioPharma Ltd. The Swedish Medical Products Agency has approved the initiation of a Phase I/IIa trial of Lytixar in nasal decolonization of methicillin-resistant Staphylococcus aureus. Synta Pharmaceuticals Corp. disclosed results from the first state of its trial for STA-9090 in patients with non-small-cell lung cancer.
ACCESSION #
50915241

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics